Browsing Tag
Evercore ISI
9 posts
Nike (NYSE: NKE) at 11-year lows: Is the Swoosh a value trap or a 2027 recovery bet?
Nike (NKE) is trading at USD 42.62, near 11-year lows. Tariffs, China and a delayed turnaround have rattled investors. Here is what the next catalyst means for NKE shareholders.
April 12, 2026
Suja Life files for Nasdaq IPO as better-for-you beverage growth meets public market scrutiny
Suja Life has filed for a Nasdaq IPO. Read why its growth, debt load, brand mix, and category timing matter more than the filing itself.
April 11, 2026
IBM and ElevenLabs bring enterprise-grade voice AI to watsonx Orchestrate, targeting regulated sectors at scale
IBM integrates ElevenLabs voice AI into watsonx Orchestrate with HIPAA and PCI controls, targeting healthcare, banking, and government. Read the full analysis.
March 27, 2026
Why KB Home is holding its $0.25 dividend steady despite housing market turbulence
KB Home keeps its $0.25 quarterly dividend. Find out what this means for investors, housing market sentiment, and dividend stability in 2025.
October 10, 2025
Enanta (NASDAQ: ENTA) prices $65m offering at $10 per share — Is this a lifeline or a warning sign?
Enanta Pharmaceuticals (NASDAQ: ENTA) raises $65M in stock offering at $10 per share. Explore dilution risks, investor sentiment, and future outlook.
October 1, 2025
Fermi America prices IPO at $21 per share ahead of Nasdaq and London listings
Fermi America prices IPO at $21, dual-listing on Nasdaq and London. Find out why investors see FRMI as a bold bet on AI-driven energy grids.
October 1, 2025
Why Evercore ISI hired Alexander Virgo now—and what it means for global industrial research
Evercore ISI hires Alexander Virgo as senior managing director in London to boost global industrial research. Find out what this means for sector coverage.
September 15, 2025
Seagate Technology beats earnings, but why did the stock plummet?
Seagate Technology Holdings plc’s (NASDAQ: STX) stock faced a sharp decline following its Q1 FY 2025 earnings report.…
October 23, 2024
Centessa Pharmaceuticals pulls off massive $225m deal—Stock price jumps
Centessa Pharmaceuticals has experienced a substantial rise in its share price after completing an upsized public offering of…
September 13, 2024